跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TENOFOVIR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
TENOFOVIR
Authorized
STANDARD
TENOFOVIR
sivem pharmaceuticals ulc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f0b5a292c4795b0e
Company
sivem pharmaceuticals ulc
Type
Standard
Approval Details
Approval Id
f0b5a292c4795b0e
Drug Approval Canada Name
TENOFOVIR
Product Name
TENOFOVIR
Status
Marketed
Status Date
2022-05-12
Original Market Date
2022-05-12
Din
02523922
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:18.08.20
Atc Original
J05AF07 TENOFOVIR DISOPROXIL
Atc Name
j 05 af 07
Aig Number
0152569001
Company Name
sivem pharmaceuticals ulc
Company Address
4705 Dobrin Street, Saint-Laurent, Quebec, Canada, H4R 2P7
Active Ingredients
TENOFOVIR DISOPROXIL FUMARATE
300 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f0b5a292c4795b0e
Type
Standard
Back to Health Canada Approvals